Telemedicine in the Covid-19 pandemic in Brazilin a medical clinic in the supplementary health sector in São Paulo, Brazil

Not Applicable

Recruiting

• Conditions: SARS-CoV; Hydroxychloroquine; B04.820.504.540.150; Telemedicine; Covid-19; 2019-CoV; B04.820.504.540.150.075; B04.820.504.540.150.113.937; H02.403.840; D03.633.100.810.050.180.350

• Registration Number: RBR-658khm
• Lead Sponsor: Centro Medico Mazzei

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-22
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients with clinical and epidemiological diagnosis of covid-19 with moderate condition and possible poor prognosis without comorbidities that prevent home treatment.

Exclusion Criteria

Do not sign the informed consent form.
Present previous heart disease / arrhythmia or associated comorbidity that requires hospital follow-up.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Better results with reduced morbidity and mortality with treatment proposed by telemedicine, score of clinical improvement of patients who followed the drug protocol.

Secondary Outcome Measures

Name	Time	Method
Analysis of population, symptomatological and epidemiological characteristics related to Covid-19. Analysis of the therapeutic approach by telemedicine.